496 related articles for article (PubMed ID: 20546453)
1. Impact of preoperative serum sodium concentration in living donor liver transplantation.
Fukuhara T; Ikegami T; Morita K; Umeda K; Ueda S; Nagata S; Sugimachi K; Gion T; Yoshizumi T; Soejima Y; Taketomi A; Maehara Y
J Gastroenterol Hepatol; 2010 May; 25(5):978-84. PubMed ID: 20546453
[TBL] [Abstract][Full Text] [Related]
2. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
[TBL] [Abstract][Full Text] [Related]
3. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
[TBL] [Abstract][Full Text] [Related]
4. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
[TBL] [Abstract][Full Text] [Related]
5. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function.
Cywinski JB; Mascha E; Miller C; Eghtesad B; Nakagawa S; Vincent JP; Pesa N; Na J; Fung JJ; Parker BM
Liver Transpl; 2008 Jan; 14(1):59-65. PubMed ID: 18161840
[TBL] [Abstract][Full Text] [Related]
6. Which score system can best predict recipient outcomes after living donor liver transplantation?
Chung IS; Park M; Ko JS; Gwak MS; Kim GS; Lee SK
Transplant Proc; 2012 Mar; 44(2):393-5. PubMed ID: 22410025
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation.
Xu X; Ling Q; Wu J; Chen J; Gao F; Feng XN; Zheng SS
Liver Int; 2007 Aug; 27(6):816-24. PubMed ID: 17617125
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based incorporation of serum sodium concentration into MELD.
Biggins SW; Kim WR; Terrault NA; Saab S; Balan V; Schiano T; Benson J; Therneau T; Kremers W; Wiesner R; Kamath P; Klintmalm G
Gastroenterology; 2006 May; 130(6):1652-60. PubMed ID: 16697729
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative changes in hyponatremia as a risk factor for prolonged mechanical ventilation after living donor liver transplantation.
Park C; Kim D; Choi J; Kim E
Transplant Proc; 2010 Nov; 42(9):3612-6. PubMed ID: 21094825
[TBL] [Abstract][Full Text] [Related]
10. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
[TBL] [Abstract][Full Text] [Related]
11. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
13. Performance of posttransplant Model for End-Stage Liver Disease (MELD) and delta-MELD scores on short-term outcome after living donor liver transplantation.
Kim JD; Choi JY; Kwon JH; Jang JW; Bae SH; Yoon SK; You YK; Kim DG
Transplant Proc; 2009 Nov; 41(9):3766-8. PubMed ID: 19917383
[TBL] [Abstract][Full Text] [Related]
14. Hyponatremia a valuable predictor of early mortality in patients with cirrhosis listed for liver transplantation.
Moini M; Hoseini-Asl MK; Taghavi SA; Sagheb MM; Nikeghbalian S; Salahi H; Bahador A; Motazedian M; Jafari P; Malek-Hosseini SA
Clin Transplant; 2011; 25(4):638-45. PubMed ID: 21077951
[TBL] [Abstract][Full Text] [Related]
15. Postoperative hyperbilirubinemia and graft outcome in living donor liver transplantation.
Marubashi S; Dono K; Nagano H; Asaoka T; Hama N; Kobayashi S; Miyamoto A; Takeda Y; Umeshita K; Monden M
Liver Transpl; 2007 Nov; 13(11):1538-44. PubMed ID: 17969209
[TBL] [Abstract][Full Text] [Related]
16. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.
Ruf AE; Kremers WK; Chavez LL; Descalzi VI; Podesta LG; Villamil FG
Liver Transpl; 2005 Mar; 11(3):336-43. PubMed ID: 15719386
[TBL] [Abstract][Full Text] [Related]
17. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
Vagefi PA; Ascher NL; Freise CE; Dodge JL; Roberts JP
Liver Transpl; 2012 Feb; 18(2):160-5. PubMed ID: 22006378
[TBL] [Abstract][Full Text] [Related]
18. Model for End Stage Liver Disease score does not predict graft survival after living donor liver transplantation.
Dulundu E; Sugawara Y; Kishi Y; Akamatsu N; Kaneko J; Makuuchi M
Hepatogastroenterology; 2006; 53(71):781-2. PubMed ID: 17086888
[TBL] [Abstract][Full Text] [Related]
19. Live donor liver transplantation in high MELD score recipients.
Selzner M; Kashfi A; Cattral MS; Selzner N; McGilvray ID; Greig PD; Levy GA; Renner EL; Grant DR
Ann Surg; 2010 Jan; 251(1):153-7. PubMed ID: 19858705
[TBL] [Abstract][Full Text] [Related]
20. A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation.
Poon KS; Chen TH; Jeng LB; Yang HR; Li PC; Lee CC; Yeh CC; Lai HC; Su WP; Peng CY; Chen YF; Ho YJ; Tsai PP
Transplant Proc; 2012 Mar; 44(2):316-9. PubMed ID: 22410005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
